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Abstract
Motivation
Obstructive sleep apnea (OSA) can impair cerebral vasoreactivity and is associated with an
increased risk of cerebrovascular disease. Unfortunately, an easy-to-use, non-invasive, por-
table monitor of cerebral vasoreactivity does not exist. Therefore, we have evaluated the
use of near-infrared diffuse correlation spectroscopy to measure the microvascular cerebral
blood flow (CBF) response to a mild head-of-bed position change as a biomarker for the
evaluation of cerebral vasoreactivity alteration due to chronic OSA. Furthermore, we have
monitored the effect of two years of continuous positive airway pressure (CPAP) treatment
on the cerebral vasoreactivity.
Methodology
CBF was measured at different head-of-bed position changes (supine to 30˚ to supine) in
sixty-eight patients with OSA grouped according to severity (forty moderate to severe,
twenty-eight mild) and in fourteen control subjects without OSA. A subgroup (n = 13) with
severe OSA was measured again after two years of CPAP treatment.
Results
All patients and controls showed a similar CBF response after changing position from
supine to 30˚ (p = 0.819), with a median (confidence interval) change of -17.5 (-10.3,
-22.9)%. However, when being tilted back to the supine position, while the control group
(p = 0.091) and the mild patients with OSA (p = 0.227) recovered to the initial baseline,
patients with moderate and severe OSA did not recover to the baseline (9.8 (0.8, 12.9)%,
p < 0.001) suggesting altered cerebral vasoreactivity. This alteration was correlated with
OSA severity defined by the apnea-hypopnea index, and with mean nocturnal arterial
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oxygen saturation. The CBF response was normalized after two years of CPAP treatment
upon follow-up measurements.
Conclusion
In conclusion, microvascular CBF response to a head-of-bed challenge measured by diffuse
correlation spectroscopy suggests that moderate and severe patients with OSA have
altered cerebral vasoreactivity related to OSA severity. This may normalize after two years
of CPAP treatment.
Introduction
Obstructive sleep apnea (OSA) is a highly prevalent disorder associated with sleepiness [1, 2],
neurocognitive impairment, cardiovascular and cerebrovascular disease [3–6], and increased
morbidity and mortality [7, 8]. Strong evidence indicates that it is an independent risk factor
for ischemic stroke (with a frequency in stroke of 30% to 80% [9–12]), including both longer
time and poorer functional outcome from rehabilitation after ischemic stroke, and an
increased risk of recurrence and mortality [13, 14]. The mechanisms responsible for those
effects remain partly unknown. It is, however, known that repeated episodes of hypoxia-reoxy-
genation and increased sympathetic activity can activate different pathogenic pathways leading
to oxidative stress, endothelial dysfunction, hypercoagulability and insulin resistance which
promote atherogenesis [15–18]. OSA, hence, alters the basic control mechanisms for regulat-
ing cerebral blood flow (CBF) by decreasing resting CBF, impairing autoregulation and reduc-
ing cerebrovascular reserve capacity [19]. A blunted cerebrovascular reactivity, typically
defined as the CBF change in response to a vasoactive stimulus such as hypercapnia, hypoxia
or breath-hold has been described in patients with OSA [20–22]. An impaired compensatory
response to cerebral hypoperfusion secondary to orthostatic hypotension has also been
described [23]. These alterations to normal cerebrovascular control interfere with brain func-
tion and render the brain more vulnerable to ischemic events as brain tissue is particularly sen-
sitive to hypoxic damage and rapid reperfusion.
There are several techniques for monitoring the state of cerebral vasoreactivity (CVR) in
patients. However, many of these techniques are expensive, have limited availability and some
are invasive and require exposure to ionizing radiation [24–28]. An optimal technique for
hemodynamic monitoring which is non-invasive, portable, continuous, able to measure at the
point-of-care or at the bed-side, and relatively inexpensive is still not present in the clinics.
Transcranial Doppler ultrasound (TCD) fulfills many of these requirements. However, arteries
cannot be insonated in part of the population, the estimation of the blood flow can be errone-
ous due to difficulties in estimating the artery diameter, and, finally, microvascular CVR could
differ from the CVR of the macrovasculature measured by TCD, specially in pathological con-
ditions [29]. Recently, diffuse correlation spectroscopy (DCS) has been proven to be a non-
invasive transcranial optical method for measuring microvascular cortical CBF [24, 30]. DCS
has been validated against other measures of CBF such as TCD [31, 32], arterial-spin labeled-
magnetic resonance imaging [33–35] and xenon computed-tomography [36], and has been
used to study the cerebral hemodynamic response derived from different stimulus such as
acetazolamide injection [32], hypercapnia [22], visual and motor stimulation [30] and ortho-
static stress [37–40] in a head-of-bed manipulation protocol.
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PLOS ONE | https://doi.org/10.1371/journal.pone.0194204 March 14, 2018 2 / 16
fondo-europeo-de-desarrollo-regional-feder/
mision-y-objetivos/, from T.D.; Instituto de Salud
Carlos III, Fondo Europeo de Desarrollo Regional,
MEDPHOTAGE (DTS16/00087), url = url = http://
pagina.jccm.es/fondosestructurales/inicio/fondos-
estructurales/fondo-europeo-de-desarrollo-
regional-feder/mision-y-objetivos/, from T.D.; The
“Severo Ochoa” Programme for Centres of
Excellence in R&D (SEV-2015-0522), url = http://
www.idi.mineco.gob.es/portal/site/MICINN/
menuitem.7eeac5cd345b4f34f09dfd1001432ea0/?
vgnextoid=cba733a6368c2310VgnVCM1000001d
04140aRCRD_choosen=en, from T.D.; The Obra
Social “la Caixa” Foundation, LlumMedBcn, url =
https://obrasociallacaixa.org/el/, from T.D.;
Institucio´ CERCA, url = http://cerca.cat/, from T.D.;
Agència de Gestio´ d’Ajuts Universitaris i de
Recerca-Generalitat (2017SGR-1380), url = http://
agaur.gencat.cat/ca/inici/, from T.D.; LASERLAB-
EUROPE IV (EU-H2020 654148), url = https://
www.laserlab-europe.eu/, from T.D.; Marie Curie
initial training network (OILTEBIA 317526), url =
https://ec.europa.eu/research/mariecurieactions/
about/innovative-training-networks_en, from T.D.;
Societat Catalana de Pneumologia, Beca SOCAP
2011, url = http://www.socapnet.org/, from A.M.;
and Sociedad Española de Neumologı´a y Cirugı´a
Toràcica, Beca SEPAR 2012, url = http://www.
separ.es/, from A.M.
Competing interests: The authors have declared
that no competing interests exist.
The key result, relevant to this work, from the studies that measured CBF response to a
mild orthostatic head-of-bed challenge [37–40] is that DCS is able to observe altered CVR in
the brain cortex affected by different conditions such as ischemic stroke. We note that even
though DCS studies are mainly limited to the frontal lobes, they have been shown to be a valid
area of measurement when looking at the CVR with other techniques [41].
We have assumed that DCS allows us to assess microvascular CBF at bedside in a safe and
well-tolerated manner and is suitable for studying CVR impairments of the frontal cortex in
OSA syndrome. This allowed us to hypothesize that, compared with non-OSA subjects,
patients with OSA would have an altered microvascular cerebral flow response to a mild ortho-
static head-of-bed challenge. We have also hypothesized that this impairment is related to
OSA severity.
Finally, we were motivated by the fact that some studies have detected an improvement of
the impaired cerebrovascular reactivity response after treatment with continuous positive air-
way pressure (CPAP) [21, 42, 43]. This allowed us to hypothesize that the CVR impairment as
measured by DCS on the frontal lobes could be ameliorated by long-term CPAP treatment.
For this purpose, we used DCS to study cerebral hemodynamic responses to a head-of-bed
position change in a group of patients with OSA with different levels of severity, and compared
their cerebral hemodynamics to a control group of healthy subjects. In addition, the effect of
CPAP on brain hemodynamic changes was evaluated in a subgroup of patients with severe
OSA after two years of CPAP treatment.
Materials and methods
Study design and participants
This study was conducted at a referral Sleep Unit (Department of Respiratory Medicine, Hos-
pital de la Santa Creu i Sant Pau) in Barcelona, Spain. The study protocol was approved by the
Ethical Committee of Clinical Investigation of Sanitary Health Management of the Hospital de
la Santa Creu i Sant Pau (EC/11/001/1166). All participants gave their informed written con-
sent. Two groups of subjects were enrolled: patients with OSA syndrome with an apnea-
hypopnea index (AHI) 5, and healthy controls (AHI< 5). OSA severity was classified in
two levels based on AHI (moderate and severe 15, and mild > 5 to 14.9 events/hour). Exclu-
sion criteria were: being older than 80 years, receiving or having previously received CPAP
treatment, presence of chronic obstructive pulmonary or neuromuscular diseases, previous
ischemic stroke, and refusal to participate in the study. Anthropometric characteristics were
obtained for all participants. A pre-established questionnaire was used to collect demographic
variables including medical history, cardiovascular risk factors and current medication. Sub-
jects were instructed to avoid caffeinated or alcoholic beverages during the hours prior to the
study. Diagnosis of arterial hypertension (AHT) was established according to European Soci-
ety of Hypertension/European Society of Cardiology criteria [44]. In a subgroup of patients
with severe OSA (AHI > 30), the measurements were repeated after at least two years of CPAP
treatment.
Sleep studies
OSA diagnosis was performed by conventional full polysomnography (Siesta, Compumedics,
Melbourne, Australia) or respiratory polygraphy (Embletta, Natus Medical, Middleton, USA)
including, at least, the following parameters: oronasal flow (thermistor and nasal cannula),
thoracoabdominal movements and pulse oximetry. The respiratory events included in the cal-
culation of the AHI were defined according to the Spanish Sleep group [45] and the American
Cerebral vasoreactivity in obstructive sleep apnea syndrome
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Sleep Disorders Association guidelines [46]. The extent of self-reported sleepiness/drowsiness
was analyzed using the Spanish version of the Epworth scale [47].
Continuous positive airway pressure titration and compliance
All patients with severe OSA received CPAP treatment [45] after the study onset and part of
these severe patients were measured with our protocol again after at least two years of treat-
ment. CPAP titration was performed by an overnight polysomnography with manual CPAP
titration or by autotitration devices [48]. Objective treatment compliance was determined by
dividing the number of hours recorded by the CPAP device’s built-in hour meter by all the
nights of the treatment period. Patients with an average use time of less than four hours per
night were considered non-compliant.
Optical methods and instrumentation
We have developed and applied a DCS system [24]. DCS uses long coherence length near-
infrared light (785 nm) to probe the tissues [49]. On the tissue surface, it monitors the light
intensity fluctuations of the speckle patterns in order to calculate an intensity autocorrelation
function of this detected light. This intensity autocorrelation function is, then, fitted using the
correlation diffusion equation in a semi-infinite geometry, obtaining a blood flow index of the
local microvasculature [24, 49]. A custom probe consisting of a detector fibre set at 2.4 cm
from a source fibre, providing information about the cerebral cortex hemodynamics, was
placed centered on the right forehead avoiding the sinuses. We have assumed that cerebral
hemodynamic changes due to orthostatic stress are global in patients without cerebrovascular
disease [37]. The microvascular blood flow index was measured continuously with a three sec-
ond temporal resolution during the study.
Head-of-bed protocol
We have used a head-of-bed position change as a mild orthostatic challenge to induce CBF
changes [37–39]. This protocol involved changing the head-of-bed angle from the supine
baseline (0˚) to 30˚ elevation and back to the initial supine position (0˚). Fig 1 illustrates the
protocol.
First, the subjects were asked to lie on a motorized movable bed to place and fix the optical
probe on their foreheads. The protocol was started after about thirty minutes of preparation.
During the experiment, the subjects were kept for five minutes in each head-of-bed position.
The transitions between head-of-bed positions lasted a maximum of thirty seconds. The rela-
tive CBF (rCBF) changes for each position were obtained by normalizing the continuous
blood flow index obtained for each position with the mean blood flow index corresponding to
the initial supine position, and averaging the normalized values corresponding to each posi-
tion. To avoid bed movement artifacts, the first minute and the last minute for each position
Fig 1. The protocol of the different head-of-bed position changes.
https://doi.org/10.1371/journal.pone.0194204.g001
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were excluded in the analysis. rCBF response to the change from the supine position to 30˚ is
represented as rCBFsupine to 30˚. rCBF response when tilting back to the initial supine position
considering the baseline as the initial supine position is represented as rCBF30˚ to supine. All
measurements were performed during the daytime.
Statistical analysis
We have expressed quantitative variables as a median and interquartile range (median (Q1,
Q3)), and categorical variables as number of cases and percentages (cases (percentages)). The
Shapiro-Wilk test was used to assess for normality. The Kruskal-Wallis test (for quantitative
dependent variables) or the Chi-squared test (for categorical dependent variables) were used
with three-way pairwise comparisons with a Bonferroni correction. The Wilcoxon signed-
rank test was used to assess the differences within the same group. The Wilcoxon rank-sum
test (for quantitative variables) or the Chi-squared (for categorical variables) test were used to
assess the differences between two groups. Spearman correlation was used to assess the corre-
lation between quantitative variables. A multiple linear model (in a forward stepwise way) was
used to linearly model the relationship between a dependent variable and the different quanti-
tative and categorical variables. p< 0.05 was considered as the threshold for rejection of the
null hypothesis for all statistical tests. All statistical analyses were performed with R [50] using
the “PMCMR” [51] package.
Results
Baseline characteristics
A cohort of eighty-two (n = 82) subjects conformed the population of this study. Sixty-eight
(n = 68) patients with OSA (forty moderate and severe, and twenty-eight mild) and fourteen
control subjects were recruited. Full polysomnography was performed on thirty-two subjects
(39%) and respiratory polygraphy on fifty subjects (61%).
Table 1 contains the demographics, clinical characteristics and sleep study results of the
included subjects. Patients with moderate and severe OSA were older than the control group
and more obese than both the patients with mild OSA and the controls. Gender distribution
was different between groups, but pairwise comparisons with a Bonferroni correction did not
provide evidence between which groups significant differences existed. Smoking, diabetes and
dyslipidemia were similar among the three groups.
None of the control subjects were receiving chronic medications. Patients with OSA, on the
other hand, were receiving chronic medications (the majority being anti-hypertensive); five
received calcium channel blockers, eight angiotensin-converting enzyme inhibitor, six beta
blockers, four diuretics, six angiotensin II receptor blockers, and two alopurinol.
Not all data (demographics, clinical characteristics, sleep study results and optical study
results) was normally distributed. For consistency, we have opted to use statistical tests that are
appropriate for non-normally distributed data.
Orthostatic cerebral blood flow challenge: Patients versus the healthy
control group
As shown in Fig 2, the category of the patients assigned according to OSA severity was not a
statistically significant factor for rCBF response to the change from the supine position to 30˚
(p = 0.819). In other words, all controls and patients showed a similar rCBF response after the
first HOB position change. However, when being tilted back to the supine position, the cate-
gory of the patients identified according to the OSA severity was a statistically significant factor
Cerebral vasoreactivity in obstructive sleep apnea syndrome
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Table 1. a) Demographics, clinical characteristics and b) sleep study results.
a)
Control (n = 14) Mild (n = 28) Moderate and severe (n = 40) p Total (n = 82)
Age (y.) 52.5 (40, 56) 53.5 (47.5, 61) 57 (50, 62) 0.040a 54 (48, 62)
Males n (%) 5 (36) 18 (64) 30 (75) 0.030 53 (65)
BMI (kg/cm2) 24 (23, 26) 28 (25, 30) 31.5 (28, 35) < 0.001b 29 (25, 33)
Epworth 7 (5, 9) 12 (8, 15) 11 (7, 14.5) 0.040c 10 (6, 14)
AHT n (%) 0 (0) 2 (7) 22 (55) < 0.001b 20 (24)
Smoker n (%) 5 (36) 17 (61) 18 (45) 0.325 49 (60)
Diabetes n (%) 0 (0) 3 (11) 9 (22.5) 0.094 11 (13)
Dyslipidemia n (%) 2 (14) 5 (18) 9 (22.5) 0.440 18 (22)
b)
AHI (n./hour) 2 (1, 4) 9 (7, 12) 48.5 (21, 78) < 0.001d 14.5 (6, 47)
Mean SpO2 (%) 95.5 (95, 96) 95 (94, 96.5) 93 (92, 95) < 0.001
b 94 (93, 96)
CT90 (%) 0 (0, 0) 0 (0, 0.3) 10 (3, 23) < 0.001b 0.4 (0, 11)
ODI4 (%) 1 (0, 3) 5 (3, 10) 44 (19, 71) < 0.001b 11 (3.5, 43)
Data shown as median (interquartile range) or number of cases (percentages).
Symbols indicate a statistically significant difference between the different groups (), the moderate and severe group with OSA versus the control group (a), the
moderate and severe group with OSA versus the other groups (b), the control group versus the mild group with OSA (c), and all the groups pairwise (d).
BMI, body mass index; AHT, arterial hypertension; AHI, apnea-hypopnea index; SpO2, arterial oxygen saturation; CT90, % of total sleep time with SpO2 lower than
90%; ODI4, 4% oxygen desaturation index; OSA, obstructive sleep apnea.
https://doi.org/10.1371/journal.pone.0194204.t001
Fig 2. rCBF response to orthostatic stress induced by a mild head-of-bed position change for the different OSA severity groups (moderate and
severe, and mild) and the control group. Measured mean data points for each patient and each head-of-bed position change, and classic boxplots for
each group and each head-of-bed position change are shown. Labels show the median (interquartile range) for each group and each head-of-bed
position change. Symbols indicate a statistically significant difference between the different groups (), the group versus the control group (†), and the
group versus the baseline (‡). rCBF, relative cerebral blood flow; OSA, obstructive sleep apnea.
https://doi.org/10.1371/journal.pone.0194204.g002
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(p = 0.004). The control group (p = 0.091) and the group with mild OSA (p = 0.227) recovered
to the initial baseline while the group with moderate and severe OSA presented a statistically
significantly higher blood flow relative to the initial supine position (p< 0.001). The recovery
response of the group with moderate and severe OSA was significantly different from that of
the control group (p = 0.003), though the recovery response of the group with mild OSA was
not significantly different from that of the control group (p = 0.174).
Association between sleep study results, demographics, clinical
characteristics, and the cerebrovascular response
No statistically significant correlations were found between rCBFsupine to 30˚ and any of the
sleep study results, demographics or clinical characteristics.
For all subjects measured, a positive statistically significant Spearman correlation
(p = 0.007, see the supplementary material “S1 Table”) was found between rCBF30˚ to supine and
AHI, and a negative significant correlation was found between rCBF30˚ to supine recovery and
mean arterial oxygen saturation (SpO2) sleep night value (p = 0.002). Other positive relevant
correlations were between rCBF30˚ to supine and % of total sleep time with SpO2 lower than 90%
(CT90) (p = 0.005), rCBF30˚ to supine and 4% oxygen desaturation index (ODI4) (p = 0.048),
and rCBF30˚ to supine and body mass index (BMI) (p = 0.005). Age was not significantly corre-
lated to rCBF30˚ to supine (rSpearman = 0.15, p = 0.199). Excluding the control group, only mean
SpO2 was found to be correlated to rCBF30˚ to supine (rSpearman = -0.28, p = 0.023).
When performing a multiple linear model with rCBF30˚ to supine as the dependent variable
versus the different sleep study results, demographics and clinical characteristics as the inde-
pendent variables, mean SpO2 was the independent variable whose inclusion gave the most
statistically significant improvement of the fit with radj
2 (percentage of the response variable
variation that is explained by a linear model) of 0.12 and a slope (β) of -2.02. No other second-
ary variables (AHI, natural logarithm of AHI, age, gender, smoking status, BMI, AHT,
diabetes, dyslipidemia, CT90, ODI4 or Epworth scale) improved the model to a statistically
significant extent. A second multiple linear model was performed excluding the control group.
Again, a model with rCBF30˚ to supine as the dependent variable and mean SpO2 as the indepen-
dent variable was found with radj
2 of 0.09 and a slope (β) of -1.71.
A full subject-wise representation of the sleep study results, demographics, clinical charac-
teristics, and optical study results can be found in the supplementary material “S2 Table”.
Cerebral vasoreactivity in obstructive sleep apnea patients after long-term
continuous positive airway pressure treatment
Thirteen (n = 13) patients with severe OSA were recruited again after 2.3 (2.0, 2.4) years of
CPAP treatment. All the patients that were recruited again had good CPAP treatment compli-
ance of 6.8 (5.3, 7.0) hours per night. Mean CPAP pressure was 10 (8-10) mmHg. Their first
use of CPAP corresponded with the day after the first optical measurement. The same protocol
(the HOB challenge) used in the first recruitment was performed again. The remaining
patients treated with CPAP were excluded due to their refusal to participate in the second part
of the study. None of the patients changed their condition with respect to diabetes, dyslipide-
mia or other relevant cardiovascular conditions (e.g. none had a stroke) during the CPAP
treatment. The weight differences before the treatment and after two years were not statisti-
cally significant (p = 0.787) either. One patient changed from being non-hypertensive to being
hypertensive together with the start of hypertensive treatment.
The supplementary table “S3 Table” contains the pre-treatment demographics, clinical
characteristics, and the sleep study results of the subgroup of patients with severe OSA
Cerebral vasoreactivity in obstructive sleep apnea syndrome
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recruited after two years of CPAP treatment compared to the rest of the group with severe
OSA measured one time, and to the complete severe OSA group. No statistically significant
differences between demographics, clinical characteristics, or sleep study results were found.
rCBF30˚ to supine was not statistically significantly different between the patients with severe
OSA remeasured and the patients measured one time (p = 0.053).
The rCBFsupine to 30˚ for the group with severe OSA remeasured was again similar to two
years before (p = 0.893). Fig 3 shows, in contrast, that after a head-of-bed change from the
supine position to 30˚ and back to the supine position, the magnitude of rCBF30˚ to supine
changed significantly from the pre- to post-CPAP period (p = 0.047). The pre-CPAP group
with severe OSA did not recover to the baseline (p = 0.001), while the post-CPAP group with
severe OSA did (p = 0.094).
A full subject-wise representation of the demographics, sleep study results, clinical charac-
teristics and optical study results of the severe patients measured before and after CPAP treat-
ment can be found in the supplementary material “S4 Table”.
Discussion
To the best of our knowledge this is the first study that evaluates the cerebral microcirculatory
vasoreactivity in response to a mild orthostatic stress in patients with OSA. The main finding
is the different response of the microvascular blood flow in patients with moderate and severe
OSA as compared to patients with mild OSA and healthy control subjects. In patients with
moderate and severe OSA the orthostatic challenge leads to an alteration of the supine CBF
upon returning to the initial HOB supine position. We found that this alteration is related to
Fig 3. rCBF recovery after a head-of-bed position change and back to the supine position in patients with severe
OSA before and after long-term CPAP treatment. Measured mean data points and classic boxplots are shown.
Median (interquartile range) are shown in labels. Symbols indicate a statistically significant difference between the
mean ranks (), and from the baseline (†). rCBF, relative cerebral blood flow; CPAP, continuous positive airway
pressure treatment.
https://doi.org/10.1371/journal.pone.0194204.g003
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OSA severity, AHI and mean SpO2, and that long-term CPAP treatment ameliorates this
alteration.
In our study with DCS, the amount of CBF change in response to a HOB from the supine
position to 30˚ was similar for all subjects measured, and in agreement with previous DCS
studies. Edlow et al. [37], in healthy patients, found a response of 18 (± 1.5)% (mean(standard
error)) cerebral blood flow. In ischemic stroke patients in a similar protocol, Durduran et al.
[39] obtained a change of 30 (±7)% and 25 (±7)% in the ipsi- and contra-infarct hemispheres
respectively, and Favilla et al. [38] applying the same protocol, found a change of 17 (±4.6)%
and 15 (±4.6)% in the ipsi- and contra-infarct hemispheres, respectively. Considering these
studies with control subjects, stroke patients and the results presented in this study including
patients with OSA, a HOB change from the supine position to 30˚ may be a too mild challenge
to be able to observe differences in the CVR of the brains of this population.
Only Edlow et al. [37], in healthy patients, evaluated the tilting back to the baseline level
finding a significant increase of 9.7 (±1.8)% in sixty patients. In our study rCBF30˚ to supine was
different between cohorts grouped by OSA severity. Patients with moderate and severe OSA
presented a significantly higher blood flow than the corresponding value at the initial supine
position, while the controls and the patients with mild OSA did not. This result suggests that
patients with OSA might need a longer time period than five minutes in each HOB position to
stabilize their hemodynamic response. This is assuming that healthy cerebral auto-regulation
would, given enough time, normalize the CBF. Urbano et al. [23] measured (by TCD) the
effect of a strong orthostatic challenge (standing to squatting position) in twenty-six patients
with moderate or severe OSA and twenty-eight control subjects, and showed that patients with
moderate or severe OSA presented an impaired compensatory response to a strong orthostatic
challenge. While the degree of change was similar between the two groups, patients with OSA
had a significantly slower rate of recovery of blood pressure, cerebral blood flow velocity and
cerebro-vascular conductance than the control group. However, this study did not consider
the correlation between OSA severity (AHI) and the recovery time. Even though there are dif-
ferences in design and protocol, the results are in accordance with our findings, showing that
patients with OSA might take a longer time than healthy subjects to recover cerebral blood
flow to baseline after an orthostatic stress. This hypothesis needs to be checked in future stud-
ies in which patients should stay for longer periods of time in each HOB position. Unfortu-
nately, this is a non-trivial set-up because of potential confounders since patients often do not
comply well with protocols including long resting periods.
Other studies have looked at the CVR in patients with OSA with conflicting results. Busch
et al. [22], who also used DCS, found that children with OSA and snorers have a blunted CBF
response to hypercapnia during wakefulness compared to a control group. Placidi et al. [52]
used a breath-holding test finding a reduction of CVR in a group of patients with severe OSA
when compared to controls. In contrast to these two studies, Foster et al. [53] and Ryan et al.
[54] did not detect differences in a small group of patients using other testing procedures for
hypercapnia induced stimulation. Reichmuth et al. [42] studied twenty patients with moderate
and severe OSA and twenty controls, showing that cerebral vasodilation response to hypoxia
and hypercapnia was smaller in patients versus controls. They also found that hypoxia induced
vasodilation in the forearm, though not vasodilatation induced by hypercapnia, was attenuated
in patients with OSA. Morgan et al. [20] described a blunted cerebrovascular response to
hyperoxic hypercapnia in a large sample of 373 participants from the Sleep Heart Health Study
cohort. They observed a positive correlation between the mean level of arterial oxygen during
sleep and vascular cerebral responsiveness to hypercapnia. In contrast, AHI was not statisti-
cally significantly associated with cerebrovascular carbon dioxide reactivity. Nasr et al. [55]
evaluated cerebral autoregulation (the arterial blood pressure-cerebral blood flow relationship)
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in patients with moderate OSA and age-matched control subjects. Cerebral autoregulation was
impaired in patients with OSA during wakefulness with a strong relationship between the
impairment and the number of apneas and hypopneas during sleep, suggesting that patients
with the most severe OSA had the strongest alteration of cerebral autoregulation.
We have found significant correlations with rCBF30˚ to supine recovery and with both
AHI and mean SpO2, though mean SpO2 was the best predictor when performing a multiple
linear model. Other tested predictors that did not improve this model were age, gender,
smoking status, BMI, AHT, diabetes, dyslipidemia, CT90, ODI4 and Epworth scale. When
considering only patients with OSA, a significant correlation with rCBF30˚ to supine recovery
and mean SpO2 was found again, and mean SpO2 was the best predictor in the multiple linear
model again. This result is in agreement with the hypothesis that the value of nocturnal satura-
tion over the number of apneas and hypopneas better predicts the degree of endothelial
impairment, which is one of the main factors involved in cerebral dysfunction in OSA [19]. In
line with our results, other authors have described a significant correlation between cerebro-
vascular reactivity and nocturnal hypoxemia [21, 43].
Impaired CVR may imply impaired cerebral autoregulation, which, in turn, may contribute
to the increased risk of stroke in patients with OSA through two physiopathological pathways:
an increased vulnerability to drops in arterial blood pressure leading to ischemia in the brain,
and, an excess of flow in vessels in the brain during surges in arterial blood pressure leading to
capillary damage [56]. In addition, impaired cerebral autoregulation might contribute to the
poorer neurological outcome that has been reported in stroke patients with associated OSA
[13].
After at least two years of CPAP treatment, thirteen patients with severe OSA were mea-
sured again and CVR was shown to have normalized. In general, no significant clinical param-
eters nor medication were changed during this period. Even though only a small group of
patients was measured again, other studies support a recovery of CVR due to CPAP treatment.
Reichmuth et al. [42] found that hypoxic vasodilation improved after twelve months of CPAP
treatment. Prilipko et al. [43] in twenty-three patients with moderate or severe OSA using a
breath-holding stimulus and functional magnetic resonance imaging, found that the CVR of
the thalamus was increased after two months of CPAP treatment, while it decreased in patients
with sham CPAP. Foster et al. [21] recruited eight patients with severe OSA who went through
isocapnic hypoxia. Cerebral blood flow velocity response was significantly lower in patients
than in control subjects, though the response was similar between patients with OSA and con-
trols after four-to-six weeks of CPAP treatment. Taken together, these results support the
claim that OSA related impairment in cerebrovascular function is reversible, at least partly,
with treatment.
Our study has some potential limitations that should be taken in consideration. First, mea-
surements were performed at different times during hospital working hours (74% of the
patients in the afternoon) without considering the fact that it has been suggested that CVR
diminishes in the morning in patients with OSA after the continuous stress of night hypox-
emia and hypercapnia. In line with this, Placidi et al. [52] found significantly lower values of
breath-holding index in the morning than in the afternoon in patients with OSA by TCD.
However, considering that the majority of moderate and severe subjects (70%) were measured
in the afternoon, this factor is not expected to affect our results. This important aspect should
be monitored in future studies.
Second, the study included patients with different OSA severity and control subjects that
were not completely matched in demographics and clinical characteristics. In particular, BMI
and AHT were significantly higher in patients with moderate and severe OSA. Chronic hyper-
tension is involved independently in the production of reactive oxygen species, inflammation,
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endothelial dysfunction and vasodilatation impairment; therefore, the association of OSA,
with a frequency in resistant hypertension of more than 80% [57], and hypertension could
have an accumulative effect [58]. Considering that 91% of AHT subjects were patients with
moderate and severe OSA, it is difficult to discriminate this effect in our dataset. Even though
differences on age were found between OSA severity groups, Edlow et al. [37] found no differ-
ence in rCBF30˚ to supine depending on age. In addition, while gender effect is not clear in our
results, Edlow et al. found it to be a significant effect. However, relevantly, when performing
the multiple linear model for rCBF30˚ to supine as the dependent variable versus the different
sleep study results, demographics, and clinical characteristics, only mean SpO2 was identified
as the best significant factor. Neither AHT, BMI, age nor gender improved the model. As men-
tioned previously, the same results were found when the analysis was only performed in
patients with OSA.
Third, the partial pressure of carbon dioxide (PCO2) was an unexplored relevant factor
since the majority of the PCO2 baseline values for the subjects included were not obtained.
PCO2 was not monitored during the orthostatic challenge. In any case, the literature shows
that while hypoxemia is a factor that clearly modifies the cerebral autoregulation in patients
with OSA, the results of the few studies that analyze cerebrovascular response to hypercapnia
are contradictory [20, 23, 42]. The role of hypercapnia in the cerebrovascular response in
patients with OSA needs to be investigated further in future studies.
Fourth, near-infrared diffuse correlation spectroscopy technique measures information
from the brain, but also contains scalp and skull contributions [59–61]. However, when fitting
only the early portion of the intensity autocorrelation function, our brain-to-scalp sensitivity
increased from 25% to 45% approximately. This brain-to-scalp sensitivity is greater than the
10% sensitivity found by near-infrared spectroscopy technique [62]. Overall, even though our
measurements contain extracerebral contributions, we can say that a relevant contribution is
due to the brain as shown by other earlier studies [30, 62, 63].
Fifth, the use of respiratory polygraphy may underestimate the apnea or hypopnea index
since the analysis does not distinguish between the awake and sleep periods, while polysomno-
graphy considers only the sleep periods. Moreover, respiratory polygraphy does not include
respiratory events that lead to arousal without a significant desaturation of the arterial blood.
This underestimation would not affect the patients currently labeled as being with severe OSA;
instead, it would affect patients listed as moderate who should have been listed as being severe.
However, since we have considered patients with moderate and severe OSA together for the
analysis, this underestimation will not affect our main findings.
Finally, when looking at the CPAP effect, only a small group of patients, though with the
strength of an excellent CPAP compliance, were reviewed. These results need to be confirmed
in the near future in a large and clinically representative sample of patients with OSA.
Conclusions
In summary, this study shows an alteration of the cerebrovascular reactivity at the level of the
microvasculature in response to a mild orthostatic challenge in patients with moderate and
severe OSA. This impairment, which is dependent on OSA severity, is an important pathoge-
netic link between OSA and vascular disease. The alteration in vascular regulation could nega-
tively impact tissue perfusion during acute episodes of apnea, and indicate a potential greater
vulnerability of the cerebral vasculature to stroke injury. For this study we have used a non-
invasive technique, DCS, which enables continuous bedside monitoring of CBF and, a mild
orthostatic head-of-bed challenge. The orthostatic stress stimulus mimics a daily action with-
out the need for pharmacological agents, hypoxemia or hypercapnia exposures, and with
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minimal patient collaboration. We propose that this stimulus together with diffuse correlation
spectroscopy can be a relatively simple and easy protocol for identifying subclinical alterations
of cerebrovascular reactivity. Finally, we found that cerebral vasoreactivity improved with
CPAP treatment in a small group of highly compliant patients, suggesting that the impairment
in cerebrovascular function may be reversible, at least in part, with treatment. Further studies
will be needed to better define the importance of this finding.
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